TITLE

Metformin Inhibits Expression and Secretion of PEDF in Adipocyte and Hepatocyte via Promoting AMPK Phosphorylation

AUTHOR(S)
Shumin Yang; Qiong Lv; Ting Luo; Lulu Liu; Rufei Gao; Shumei Chen; Peng Ye; Qingfeng Cheng; Qifu Li
PUB. DATE
January 2013
SOURCE
Mediators of Inflammation;2013, Vol. 2013, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective. Pigment epithelium-derived factor (PEDF) plays an important role in obesity-induced insulin resistance (IR). The study aims to investigate the effect of metformin, a widely used agent to improve IR, on PEDF production both in vivo and in vitro. Methods. SD rats were divided into normal control group, high fat group (HF group), and metformin group (MET group). Hyperinsulinemic euglycemic clamp was performed to evaluate insulin sensitivity. IR models of 3T3-L1 and HepG2 cells were established and then treated with metformin and inhibitor of AMP activated protein kinase (AMPK). Results. In vivo, the HF group showed increased serum PEDF which is negatively correlated with insulin sensitivity, while the MET group revealed decreased serum PEDF and downregulated PEDF expression in fat and liver, concomitant with significantly improved IR. In vitro, the IR cells showed enhanced PEDF secretion and expression, whereas metformin lowered PEDF secretion and expression, accompanied with increased glucose uptake. Metformin stimulated AMPK phosphorylation in fat and liver of the obese rats, while in vitro, when combined with AMPK inhibitor, the effect of metformin on PEDF was abrogated. Conclusions. Metformin inhibits the expression and secretion of PEDF in fat and liver via promoting AMPK phosphorylation, which is closely associated with IR improvement.
ACCESSION #
94866181

 

Related Articles

  • Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance. Moreno-Navarrete, J M; Touskova, V; Sabater, M; Mraz, M; Drapalova, J; Ortega, F; Serrano, M; Catalán, V; Gómez-Ambrosi, J; Ortiz, M R; Pardo, G; Pueyo, N; Ricart, W; Lacinova, Z; Haluzik, M; Frühbeck, G; Fernández-Real, J M // International Journal of Obesity;Sep2013, Vol. 37 Issue 9, p1230 

    Objective:Recent studies linked circulating pigment epithelium-derived factor (PEDF) to obesity-associated insulin resistance, but the main source of circulating PEDF is unknown. We aimed to investigate liver and adipose tissue PEDF gene expression in association with obesity and insulin...

  • PEDF Expression Is Inhibited by Insulin Treatment in Adipose Tissue via Suppressing 11β-HSD1. Zhou, Yinli; Xu, Fen; Deng, Hongrong; Bi, Yan; Sun, Weiping; Zhao, Yi; Chen, Zonglan; Weng, Jianping // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Early intensive insulin therapy improves insulin sensitivity in type 2 diabetic patients; while the underlying mechanism remains largely unknown. Pigment epithelium-derived factor (PEDF), an anti-angiogenic factor, is believed to be involved in the pathogenesis of insulin resistance. Here, we...

  • Reduced Expression of p70S6 Kinase Rescues 3T3-L1 Adipocytes from Constitutively Active Akt Induced Insulin Resistance due to Serine Phosphorylation of IRS-1. Adochio, Rebecca L.; Hedlund, Reed A.; Leitner, J. W.; Draznin, Boris // Diabetes;Jun2007 Supplement 1, Vol. 56, pA332 

    Phosphorylation of IRS-1 on serine residues 307 and 636 has been recognized as a feedback mechanism responsible for insulin resistance and diminution of insulin action. Activation of p70S6 kinase by nutrients, Akt, and insulin has been identified as a pathway leading to phosphorylation of IRS-1...

  • Resistin is expressed in human hepatocytes and induces insulin resistance. Jun Di; Yong Jin; Yu Zhang; Mei Wu; Ying Sun; Gui Zhang // Endocrine (1355008X);Apr2008, Vol. 33 Issue 2, p135 

    Abstract  Resistin, known as an adipocyte-specific secretory factor (ADSF), is implicated to modulate insulin resistance in rodents. However, the precise role of this factor for human insulin resistance has remained elusive. Here, we investigate the relationship between human resistin and...

  • NYGGF4 ( PID1) effects on insulin resistance are reversed by metformin in 3T3-L1 adipocytes. Qiu, Jie; Wang, Yu-mei; Shi, Chun-mei; Yue, Hong-ni; Qin, Zhen-Ying; Zhu, Guan-zhong; Cao, Xin-guo; Ji, Chen-bo; Cui, Yan; Guo, Xi-rong // Journal of Bioenergetics & Biomembranes;Dec2012, Vol. 44 Issue 6, p665 

    NYGGF4 (also called PID1) is a recently discovered gene that is involved in obesity-related insulin resistance (IR). We aimed in the present study to further elucidate the effects of NYGGF4 on IR and the underlying mechanisms through using metformin treatment in 3T3-L1 adipocytes. Our data...

  • An energetic tale of AMPK-independent effects of metformin. Miller, Russell A.; Birnbaum, Morris J. // Journal of Clinical Investigation;Jul2010, Vol. 120 Issue 7, p2267 

    Metformin has become a mainstay in the modest therapeutic armamentarium for the treatment of the insulin resistance of type 2 diabetes mellitus. Although metformin functions primarily by reducing hepatic glucose output, the molecular mechanism mediating this effect had remained elusive until...

  • CHARACTERIZATION OF INSULIN SENSITIVITY AND SIGNALING IN ADIPOCYTES FROM CONGENIC RATS. Guirguis, Emilia; Berger, Karin; Luthman, Holger; Degerman, Eva // Diabetologia Croatica;Sep2012, Vol. 41 Issue 2, p77 

    Genetic analysis of the diabetic Goto-Kakizaki rat has identified a major diabetes quantitative trait locus (Niddm1). Congenic strains generated for two different subloci, Niddm1f and Niddm1i, show defects in insulin action and secretion, respectively. In this work, we demonstrated that...

  • Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation Ando, Chieko; Takahashi, Nobuyuki; Hirai, Shizuka; Nishimura, Kanako; Lin, Shan; Uemura, Taku; Goto, Tsuyoshi; Yu, Rina; Nakagami, Joji; Murakami, Shigeru; Kawada, Teruo // FEBS Letters;Nov2009, Vol. 583 Issue 22, p3649 

    Abstract: Interaction between adipocytes and macrophages contributes to the development of insulin resistance in obese adipose tissues. In this study, we examined whether luteolin, food-derived flavonoid, could suppress the production of inflammatory mediators of the interaction between...

  • Pigment Epithelium-Derived Factor, Insulin Sensitivity, and Adiposity in Polycystic Ovary Syndrome: Impact of Exercise Training. Joham, Anju E.; Teede, Helena J.; Hutchison, Samantha K.; Stepto, Nigel K.; Harrison, Cheryce L.; Strauss, Boyd J.; Paul, Eldho; Watt, Matthew J. // Obesity (19307381);Dec2012, Vol. 20 Issue 12, p2390 

    Pigment epithelium-derived factor (PEDF) is upregulated in obese rodents and is involved in the development of insulin resistance (IR). We aim to explore the relationships between PEDF, adiposity, insulin sensitivity, and cardiovascular risk factors in obese women with polycystic ovary syndrome...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics